Romidepsin Is Effective and Well-Tolerated In Patients ≥ 60 Years Old With Relapsed Or Refractory Peripheral T-Cell Lymphoma (PTCL): Analysis From Phase 2 Trials

被引：1
|
作者：
Shustov, Andrei R.
Coiffier, Bertrand
Horwitz, Steven M.
Sokol, Lubomir
Pro, Barbara
Nielsen, Tina
Wolfson, Julie
Balser, Barbara E.
Eisch, Robin
Popplewell, Leslie
Prince, Miles
Allen, Steven L.
Piekarz, Richard
Bates, Susan E.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Romidepsin Is Effective and Well-Tolerated in Patients >= 60 Years Old With Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL): Analysis From Phase 2 Trials
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2014, 12 (02) : 17 - 18
  • [2] Romidepsin Is Effective and Well-Tolerated in Patients >= 60 Years Old With Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL): Analysis From Phase 2 Trials Commentary
    Horwitz, Steven M.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2014, 12 (02) : 19 - 22
  • [3] The Pralatrexate - Romidepsin Doublet: A Well Tolerated and Highly Effective Combination for Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
    Amengual, Jennifer E.
    Lichtenstein, Renee
    Rojas, Celeste
    Sawas, Ahmed
    Deng, Changchun
    Lichtenstien, Emily
    Kahn, Karen
    Lue, Jennifer Kimberly
    Liu, Yuxuan
    Qiao, Changhong
    Nandakumar, Renu
    Cremers, Serge
    O'Connor, Owen A.
    BLOOD, 2016, 128 (22)
  • [4] Romidepsin is effective and well tolerated in older patients with peripheral T-cell lymphoma: analysis of two phase II trials
    Shustov, Andrei
    Coiffier, Bertrand
    Horwitz, Steven
    Sokol, Lubomir
    Pro, Barbara
    Wolfson, Julie
    Balser, Barbara
    Eisch, Robin
    Popplewell, Leslie
    Prince, H. Miles
    Allen, Steven L.
    Piekarz, Richard
    Bates, Susan
    LEUKEMIA & LYMPHOMA, 2017, 58 (10) : 2335 - 2341
  • [5] Analysis of Patients with Common Peripheral T-Cell Lymphoma Subtypes From a Phase 2 Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma
    Coiffier, Bertrand
    Pro, Barbara
    Prince, H. Miles
    Foss, Francine M.
    Sokol, Lubomir
    Greenwood, Matthew
    Caballero, Dolores
    Borchmann, Peter
    Morschhauser, Franck
    Wilhelm, Martin
    Pinter-Brown, Lauren
    Padmanabhan, Swaminathan
    Shustov, Andrei R.
    Nichols, Jean
    Carroll, Susan
    Balser, John
    Horwitz, Steven M.
    BLOOD, 2011, 118 (21) : 272 - 272
  • [6] Pooled analysis of romidepsin in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL) following prior systemic therapy
    Bates, Susan
    Foss, Francine
    Piekarz, Richard
    Horwitz, Steven
    Pro, Barbara
    Prince, Miles
    Sokol, Lubomir
    Greenwood, Matthew
    Caballero, Dolores
    Borchmann, Peter
    Morschhauser, Franck
    Wilhelm, Martin
    Pinter-Brown, Lauren
    Padmanabhan, Swaminathan
    Shustov, Andrei
    Wright, John
    Kirschbaum, Mark
    Zain, Jasmine
    Allen, Steven L.
    Jaffe, Elaine S.
    Nichols, Jean
    Wolfson, Julie
    Balser, John
    Coiffier, Bertrand
    ANNALS OF ONCOLOGY, 2011, 22 : 22 - 22
  • [7] Results of a Phase 2 NCI Multicenter Study of Romidepsin in Patients with Relapsed Peripheral T-Cell Lymphoma (PTCL)
    Piekarz, Richard
    Wright, John
    Frye, Robin
    Allen, Steven L.
    Craig, Michael
    Geskin, Larisa
    Hutchins, Laura
    Joske, David
    Kirschbaum, Mark
    Leonard, John P.
    Prince, Miles
    Reeder, Craig B.
    Jaffe, Elaine
    Bates, Susan
    BLOOD, 2008, 112 (11) : 555 - 556
  • [8] Responses to romidepsin by line of therapy in patients with relapsed/refractory (R/R) peripheral T-cell lymphoma (PTCL).
    Foss, Francine M.
    Pro, Barbara
    Prince, H. Miles
    Sokol, Lubomir
    Greenwood, Matthew
    Caballero, Dolores
    Horwitz, Steven M.
    Coiffier, Bertrand
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [9] Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma
    Horwitz, Steven M.
    Kim, Youn H.
    Foss, Francine
    Zain, Jasmine M.
    Myskowski, Patricia L.
    Lechowicz, Mary Jo
    Fisher, David C.
    Shustov, Andrei R.
    Bartlett, Nancy L.
    Delioukina, Maria L.
    Koutsoukos, Tony
    Saunders, Michael E.
    O'Connor, Owen A.
    Duvic, Madeleine
    BLOOD, 2012, 119 (18) : 4115 - 4122
  • [10] Final Results of a Phase 2 NCI Multicenter Study of Romidepsin in Patients with Relapsed Peripheral T-Cell Lymphoma (PTCL).
    Piekarz, Richard
    Wright, John
    Frye, Robin
    Allen, Steven L.
    Joske, David
    Kirschbaum, Mark
    Lewis, Ian D.
    Prince, Miles
    Smith, Sonali
    Jaffe, Elaine S.
    Bates, Susan
    BLOOD, 2009, 114 (22) : 661 - 662
12345